Blog

  • QorusDocs Named Best Proposal Management Software by Info-Tech SoftwareReviews and LegalTech Breakthrough Awards

    QorusDocs Named Best Proposal Management Software by Info-Tech SoftwareReviews and LegalTech Breakthrough Awards

    SEATTLE, WA / ACCESS Newswire / November 13, 2025 / QorusDocs, a leader in AI-powered value and proposal management software, has been recognized as the #1 proposal management solution by Info-Tech Research Group’s SoftwareReviews and awarded Proposal Management Software of the Year by the LegalTech Breakthrough Awards.

    “Our priority at QorusDocs is to streamline complex proposal and RFP processes for business development teams in professional services,” said Ray Meiring, CEO of QorusDocs. “These recognitions reflect our customers’ success-higher productivity, more consistency, and more time invested in client relationships and growth.”

    QorusDocs’ recognition as the top proposal management platform comes at a pivotal time as professional services organizations seek proven ways to harness AI, prove value to clients and stay ahead in a rapidly evolving landscape. According to the Thomson Reuters 2025 Generative AI in Professional Services Report, 95% of people in professional services believe AI will be central to their organization’s workflow within the next five years.

    Info-Tech SoftwareReviews: Top Proposal Management Software

    In SoftwareReviews’ Proposal Management Data Quadrant, QorusDocs ranks highest for product features and satisfaction as well as vendor experience and capabilities. The Info-Tech Buyer Experience Report (BXR), published in October 2025, highlights QorusDocs’ exceptional scores for product performance and customer relationships.

    According to a survey of QorusDocs users:

    • 100% say QorusDocs is critical to their success

    • 100% say it increases productivity

    • 100% plan to renew with QorusDocs

    • 96% love using QorusDocs

    • 93% would recommend QorusDocs

    • 81% believe the value outweighs the cost

    LegalTech Breakthrough Awards: Proposal Management Software of the Year

    LegalTech Breakthrough Awards, an independent market intelligence organization that evaluates and recognizes standout legal technology companies, products and services around the globe, selected QorusDocs as the Proposal Management Software of the Year.

    QorusDocs enables dozens of Am Law 200 and Global 200 Law Firms to automate pitches, proposals and RFP responses, boosting productivity by up to 60% and reducing formatting time by 50%. Capabilities include auto-generating first drafts, centralizing attorney bios, case studies, and credentials, and ensuring firm branding consistency.

    QorusDocs integrates with core law firm platforms, including Litera, Intapp Deal Cloud and Microsoft 365, to help firms produce winning proposals. The Pursuits feature helps law firms with managing collaboration and automation of the pitch process. Built on the Microsoft Azure OpenAI Service, QorusDocs addresses data security, compliance and privacy for law firms’ private content libraries, past RFPs, proposals, and internal documents.

    “Many large firms handle over 500 pitches per year, translating into thousands of non-billable hours devoted to repetitive, manual tasks,” said Bryan Vaughn, managing director of LegalTech Breakthrough. “Through its advanced AI-driven automation, seamless integration, and focus on the needs of legal teams, QorusDocs modernizes the proposal process, allowing legal professionals to reduce errors, increase efficiency and productivity, maintain brand consistency and win more business. We’re so pleased to recognize QorusDocs with ‘Proposal Management Software of the Year!’”

    Continued Product Innovation: Introducing QorusDocs Value Management and New Agentic Features to Drive Further Automation

    After acquiring AI-powered customer value management software Shark Finesse earlier this year, QorusDocs introduced Value Management, a collaborative solution for building out value assessments that helps revenue teams articulate and quantify business cases in their proposals, in October. Unlike traditional Excel-based approaches, QorusDocs Value Management drives standardized data-driven value models across the organization, ensuring consistency, accuracy and trust in the numbers. Firms and customers can collaborate and build business cases together, increasing engagement and credibility. 

    Additionally, at an October 28 customer event, QorusDocs previewed new AI agents and features coming to the platform in 2026 that will draw on deep industry expertise to help revenue teams draft, personalize and refine critical sales documents even faster. Users will be able to ask an AI agent to perform repeatable or complex tasks, such as finding content, researching information and creating documents.

    Over 25,000 people globally use QorusDocs, including dozens of Am Law 200 and Global 200 law firms. To learn more, visit www.qorusdocs.com.

    About QorusDocs

    QorusDocs is a Bellevue, WA-based leader in AI-powered Value and Proposal Management software, helping organizations prove ROI and win more business. The platform unites value management with proposal automation, enabling teams to build intelligent business cases and create personalized, data-driven pitches, presentations, proposals, and RFP responses. QorusDocs empowers business development, sales, marketing, and proposal teams to collaborate seamlessly, demonstrate measurable impact, and accelerate decisions.

    For more information, visit qorusdocs.com or follow us on LinkedIn.

    PR Contact

    Anna Rice
    anna.rice@alpinemarketingcomms.com

    SOURCE: QorusDocs

    View the original press release on ACCESS Newswire

  • Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

    Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

    Continued execution on collaborations and exploratory investigator-initiated studies with institutional partners

    Secured net proceeds of approximately $3.9 million from October 2025 offering

    FRAMINGHAM, MA / ACCESS Newswire / November 13, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers, today reported its financial results for the third quarter 2025.

    “We are steadily building the foundation for potentially transformative progress in the oncology treatment paradigm as we advance our systemic DNase I program in combination with established cancer therapies,” commented James Parslow, Interim Chief Executive Officer and Chief Financial Officer of Xenetic. “The partnerships we’ve formed continue to generate critical data that we believe will help us guide our development and regulatory strategies to fully realize the promise of our DNase technology. The underwritten public offering we completed in October 2025 extends our cash runway and provides us additional capital to continue to invest in pre-clinical efforts and exploratory studies and advance our technology toward an IND submission and Phase 1 initiation.”

    Xenetic continues to advance its DNase-based technology towards Phase 1 clinical development for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors. Preclinical proof-of-concept studies combining DNase I with chemotherapy, immunotherapies, and CAR-T therapy in hematological and solid tumor and metastatic cancer models have been completed. Building on proof-of-concept success, the program has now advanced to mechanism-of-action and translational studies in preparation for a Phase 1 clinical trial.

    Additionally, as previously announced in December 2024, Xenetic entered into a Clinical Trial Services Agreement with PeriNess, under which PeriNess will lead in the regulatory approval, operational execution and management of potential exploratory, investigator initiated studies of recombinant DNase as an adjunctive treatment in patients with pancreatic carcinoma and other locally advanced or metastatic solid tumors receiving chemotherapy and immunotherapy in Israeli medical centers.

    Summary of Financial Results for Third Quarter 2025
    Net loss for the quarter ended September 30, 2025 was approximately $0.5 million. Research & development expenses for the three months ended September 30, 2025 increased by approximately $0.4 million, or 105.6%, to approximately $0.8 million from $0.4 million in the comparable quarter in 2024 primarily due to increased manufacturing development efforts and pre-clinical research as well as increased consulting costs. General and administrative expenses for the three months ended September 30, 2025 increased by approximately $0.1 million, or 9.3%, to approximately $0.8 million from approximately $0.7 million in the comparable quarter in 2024 primarily due to increased legal costs in connection with the Company’s strategic review process.

    Revenue for the three months ended September 30, 2025 increased by approximately $0.4 million, or 67.2%, to approximately $1.0 million from approximately $0.6 million for the three months ended September 30, 2024. This increase represented an increase in royalty revenue related to Xenetic’s sublicense agreement with Takeda Pharmaceuticals Co. Ltd. as compared to the same period in 2024 primarily due to royalties recognized from certain countries during the third quarter of 2025 compared to the same period in 2024.

    The Company ended the quarter with approximately $4.1 million cash. Subsequent to quarter end, the Company closed an underwritten offering for net proceeds of approximately $3.9 million.

    About Xenetic Biosciences
    Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The Company’s DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression. Xenetic is currently focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors.

    For more information, please visit the Company’s website at www.xeneticbio.com and connect on X, LinkedIn, and Facebook.

    Forward-Looking Statements
    This press release contains forward-looking statements that we intend to be subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical facts may constitute forward-looking statements within the meaning of the federal securities laws. These statements can be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates,” “remain,” “focus”, “confidence in”, “potential”, “continue”, “advance”, “fully realize”, “promise”, and other words of similar meaning, including, but not limited to, all statements regarding expectations for our DNase-base oncology platform, including statements regarding: potentially transformative progress in the oncology treatment paradigm as we advance our systemic DNase I program in combination with established cancer therapies; our partnerships continuing to generate critical data that we believe will help us guide our development and regulatory strategies to fully realize the promise of our DNase technology; plans to continue to invest in pre-clinical efforts and exploratory studies and advance our technology toward an IND submission and Phase 1 initiation; plans to advance our DNase-based oncology technology towards Phase 1 clinical development for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors; plans to build on proof-of-concept success; expectations regarding mechanism-of-action and translational studies in preparation for a Phase 1 clinical trial; expectations regarding our partnership with PeriNess and anticipated outcomes under the clinical services agreement; our focus on advancing innovative immune-oncology technologies addressing difficult to treat cancers; expectations regarding the DNase platform improving outcomes of existing treatments, including immunotherapies, by targeting NETs, which are involved in cancer progression; and our focus on advancing our systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors. Any forward-looking statements contained herein are based on current expectations and are subject to a number of risks and uncertainties. Many factors could cause our actual activities, performance, achievements, or results to differ materially from the activities and results anticipated in forward-looking statements. Important factors that could cause actual activities, performance, achievements, or results to differ materially from such plans, estimates or expectations include, among others, (1) unexpected costs, charges or expenses resulting from our manufacturing and collaboration agreements; (2) unexpected costs, charges or expenses resulting from the licensing of the DNase platform; (3) uncertainty of the expected financial performance of the Company following the licensing of the DNase platform; (4) failure to realize the anticipated potential of the DNase or PolyXen technologies; (5) the ability of the Company to obtain funding and implement its business strategy; (6) risks and uncertainties as to the outcome and timing of the strategic review process being conducted by the Board and a special independent committee thereof, including the possibility that the Board may decide not to undertake a strategic alternative following the evaluation process, the Company’s inability to consummate any proposed strategic alternative resulting from the review due to, among other things, market, regulatory and other factors, the potential for disruption to our business resulting from the review process, and potential adverse effects on the Company’s stock price from the announcement, suspension or consummation of the evaluation process and the results thereof, as well as risks and uncertainties related to the potential impacts of consummation of a strategic transaction on the Company’s current business operations, anticipated business strategy and product development plans; and (7) other risk factors as detailed from time to time in the Company’s reports filed with the SEC, including its annual report on Form 10-K, periodic quarterly reports on Form 10-Q, current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive. In addition, forward-looking statements may also be adversely affected by general market factors, general economic and business conditions, including potential adverse effects of public health issues, and geopolitical events, such as the conflicts in Ukraine and in the Middle East, on economic activity, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new product candidates and indications, manufacturing issues that may arise, patent positions, litigation, and shareholder activism, among other factors. The forward-looking statements contained in this press release speak only as of the date the statements were made, and the Company does not undertake any obligation to update forward-looking statements, except as required by law.

    CONTACT:
    JTC Team, LLC
    Jenene Thomas
    (908) 824-0775
    xbio@jtcir.com

    SOURCE: Xenetic Biosciences, Inc.

    View the original press release on ACCESS Newswire

  • FAEMA Launches FAEMINA in the United States: The Italian Espresso Experience, Redefined for Home and Small Spaces

    FAEMA Launches FAEMINA in the United States: The Italian Espresso Experience, Redefined for Home and Small Spaces

    FAEMA, the legendary Italian espresso brand from the Cimbali Group, proudly announces the U.S. debut of FAEMINA, its first high-end espresso machine designed specifically for the home, office, and small business market. FAEMINA unites timeless Italian craftsmanship, advanced technology, and contemporary design to make barista-quality coffee accessible anywhere.

    NEW YORK CITY, NEW YORK / ACCESS Newswire / November 13, 2025 / A Machine Born from Italian Excellence

    Faemina-Professional-Espresso-Machine
    Faemina-Professional-Espresso-Machine
    Faemina combines professional performance with Italian design

    Designed by ItalDesign, FAEMINA embodies Italian design values: elegance, functionality, and precision craftsmanship. Its minimalist aesthetic complements modern interiors while housing the same performance DNA that defines FAEMA’s professional machines. Every detail is engineered for ease of use and consistency, ensuring perfect extractions cup after cup.

    Professional Performance, Simplified for Everyday Use

    Hand-built in Italy, FAEMINA brings professional-grade technology to a compact, plug-and-play format. Key features include:

    • Dual Boiler System for simultaneous brewing and steaming.

    • Smart Temperature Control for pre-infusion and stable extraction.

    • Wide drink Range: from espresso to filter coffee and tea infusions.

    • Optional AutoSteam function forperfect milk at the touch of a button.

    • Internal Water Tank delivers stability and convenience.

    This combination allows anyone, from coffee lovers to first-time users, to enjoy café-quality espresso and milk-based beverages without technical expertise.

    Beyond Home: The New Standard for Small Businesses

    FAEMINA is ideal not only for the home but also for boutiques, concept stores, hotel lounges, and small offices seeking a premium coffee experience. Compact yet powerful, it turns coffee preparation into a visual and sensory ritual, transforming any space into a corner of Italian hospitality.

    Accessible Luxury: How to Buy

    FAEMINA is now available in the United States through:

    A range of accessories and finishes allows customers to personalize their setup, ensuring FAEMINA fits seamlessly into every environment.

    Why Choose FAEMINA:

    • Authentic Italian Heritage: From the makers of the iconic FAEMA E61, a milestone in espresso technology.

    • Designed for Modern Living: Compact, quiet, and built to perform.

    • Sustainable Craftsmanship: High-quality materials designed to last.

    • Versatility: Ideal for espresso, cappuccino, latte art, and specialty brews. With dedicated filter coffee and infusion tea functions, it lets you set the perfect temperature for every drink.

    FAEMINA represents the evolution of espresso, combining form, function, and emotion to bring the authentic Italian café experience into everyday life.

    Availability and Contact

    Discover FAEMINA today at www.faema.com or on Amazon.com.

    About FAEMA

    Founded in Milan in 1945, FAEMA is part of Cimbali Group, one of the world’s leading manufacturers of professional coffee machines. The brand defined the history of espresso through innovation, design, and Italian craftsmanship. FAEMA introduced the legendary E61, the first machine to use a volumetric pump to deliver consistent nine-bar pressure, revolutionizing espresso preparation. Today, FAEMA continues to merge technology and tradition to create machines that embody the art of Italian coffee culture, from professional cafés to homes worldwide.

    Instagram: @faema_official | @faemina_official

    Contact Information

    Faema Marketing
    Marketing Team
    marketing@cimbaligroup.com

    .

    SOURCE: FAEMA

    Related Documents:

    View the original press release on ACCESS Newswire

  • Franchise Builders Announces Strategic Partnership

    Franchise Titan Janice Charles Joins Team to Launch Next-Gen Franchising Platform

    CHATTANOOGA, TN / ACCESS Newswire / November 13, 2025 / Franchise Builders™, the high-velocity engine dedicated to scaling franchise systems, today announced a strategic partnership with Janice Charles, one of the most respected voices in the franchising industry. With a network of hundreds of franchisors representing more than 15,000 locations, Ms. Charles brings unparalleled influence, insight and reach – enabling Franchise Builders™ to accelerate its mission of transforming the way franchises form, scale and transact.

    Franchise Builders™’ vision: Using AI, automation and ecosystem infrastructure, Franchise Builders™ provides the solution for emerging and established franchisors to launch, manage and grow at scale. By formalizing this partnership with Janice Charles, Franchise Builders™ is taking a major leap towards its goal to become the “MLS of Franchising”: the go-to platform where franchise systems are listed, matched, benchmarked and scaled. “Partnering with Janice marks a turning point in our mission,” said Nash Bowen, Founder of Kronos Capital™, the private equity firm backing Franchise Builders™. “Her credibility across the franchising ecosystem gives us access to early brand adoption, system-wide data and operational insight – positioning us to be the backbone of the next generation of franchise growth.”

    Partnership with Janice Charles: With 40+ years of franchise experience (including time as a franchisee, franchise-system operator, and franchise consultant), Janice Charles has developed deep relationships across the industry, worked with top consumer brands and guided hundreds of franchisor systems through growth phases. Her appointment as an equity partner ensures Franchise Builders™ not only builds powerful technology – but builds it in lock-step with the realities of franchisor needs, unit economics, brand consistency and operational scalability. “I’m excited to join forces with Franchise Builders™,” said Janice Charles. “Franchise systems have long needed a unified, technology-forward platform that handles discovery, performance benchmarking, system optimization and growth. Together we can give franchisors the tools and visibility they deserve – and unlock value for the entire network.”

    Strategic partnership highlights:

    • Janice Charles will leverage her network of franchisors to integrate the Franchise Builders™ platform, enable pilot programs and accelerate adoption across thousands of units.

    • Franchise Builders™ will embed Janice’s thought-leadership, best practices and franchise operator feedback into its platform road map – aligning product development with real-world brand growth levers.

    • Together they will co-launch features that bring transparency, benchmarking and discovery to the franchise space – enabling brands, advisors and investors to access a centralized, efficient marketplace for franchise models, growth stages, capital raising and unit performance.

    About Franchise Builders™

    Franchise Builders™ is a franchise platform designed to accelerate unit expansion through AI-driven tooling, performance analytics, efficient infrastructure and monetization features, allowing franchisors to streamline development, monitor performance, optimize royalties, and scale faster.

    About Janice Charles

    Janice Charles is a leading franchise industry consultant and operator with more than four decades of experience as a franchisee, franchisor advisor and system growth strategist. She is widely recognized for her deep domain expertise, brand relationships, integrity in franchising, and success scaling leading franchise networks.

    Contact Information

    Luke DeFrino
    Marketing Manager
    luke@kronoscapital.us
    (860) 388-7488

    .

    SOURCE: Kronos Media

    View the original press release on ACCESS Newswire

  • Femm Parlour Opens in New York City, Turning Intimate-Health Conversations Into Care

    New York, NY November 13, 2025 –(PR.com)– FEMM Parlour (FEMM) has opened in New York City to turn dismissed intimate-health concerns into clear plans of care, through cutting-edge technology.

    Many women facing intimate health challenges are often dismissed by providers who attribute these issues to gender, FEMM refuses to accept that these concerns are just a part of being women. Through FDA-approved treatments common issues are effectively addresses, with no pain, stigma or downtime.

    At FEMM, empowerment is not a slogan, it’s the standard of care. The process starts with a private consultation where patients are heard, without euphemisms. From that conversation, each woman receives a personalized plan explained in plain language, alongside built-in follow-ups so progress is tracked and care evolves. The goal is simple: give women answers they can trust and steps they can take now, not someday.

    “We’re not just a clinic; we’re a movement,” said Gina Cappelli. “We’re building a space where intimate health is approached with dignity and clarity, ensuring that every woman can confidently address her unique needs. We take concerns that have been minimized or dismissed and turn them into a plan of action.”

    That plan of action is deliberately designed around a woman’s life, not the other way around. Care is delivered in straightforward terms, and the experience emphasizes comfort throughout. Non-surgical options are selected for practicality and accessibility, with no pain and no downtime, so women do not have to choose between addressing their health and keeping their day intact.

    “Awareness matters but women are ready for answers,” said Cindy Barshop. “Our job is to listen, to lay out options without pressure, and to guide her through a plan that feels comfortable and credible. The measure of success is not a good conversation; it’s a woman walking out with next steps she believes in.”

    FEMM’s approach extends beyond the appointment. When appropriate, clinicians integrate clinically informed intimacy tools to support at-home continuity between visits, keeping momentum steady without turning care into a performance. Every touchpoint reinforces the same idea: progress should be visible, supported, and personal.

    “This is the clinic we wished existed,” added Cappelli. “It’s precise and empathetic. It centers a woman’s goals and builds a path that meets her where she is. No one should have to navigate intimate health alone.”

    FEMM was built for the woman who is done waiting, who wants clarity instead of guesswork, who wants to feel at home in her body at every stage of life. By replacing stigma with straight talk and inertia with step-by-step care FEMM turns intention into outcome, one private consult, one personalized plan, and one documented follow-up at a time.

    Media note: Editorial walk-throughs and clinician interviews are available on request.

    About FEMM Parlour

    FEMM Parlour is a New York City destination for women’s intimate wellness. Cindy Barshop has joined forces with Gina Cappelli and Maria Trusa to offer discreet consultations, physician guided non-surgical treatments, and a curated selection of clinically informed intimacy products. The clinic’s focus is practical, dignified solutions that help women feel at home in their bodies at every stage of life.

    Website: www.femmparlour.com
    Instagram: @femmparlour
    Media Contact: Eleonora Mercier | ellie@marketlycollective.com | (973) 900-1708

    Contact Information:
    Femm Parlour
    Eleonora Mercier
    +1 9739001708
    Contact via Email

    Read the full story here: https://www.pr.com/press-release/953134

    Press Release Distributed by PR.com

  • CreditBlockchain Launches Cloud Mining Platform for BTC, ETH, and BNB Holders

    Denver, CO November 12, 2025 –(PR.com)– CreditBlockchain has announced the launch of an AI-powered cloud mining platform that supports BTC, XRP, and SOL mining. The platform features automated hashrate allocation, publicly verifiable withdrawals, and access via mobile devices or web browsers.

    Platform Highlights:

    – Intelligent scheduling: The system analyzes factors such as mining difficulty, energy use, and network conditions to automatically allocate computing power across multiple mining pools and asset types.

    – Automated settlement: The platform calculates user account balances daily based on mining performance. Users may withdraw balances to a personal wallet or maintain them within the platform for continued participation.

    – Mobile and web access: The platform’s interface is designed for both mobile and web use, allowing users to view computing allocations, mining status, and account information.

    – Transparency: Each mining plan displays its pricing, term, and cost details. Withdrawal transactions can be verified on a public blockchain.

    – Standardized operation: Parameters and rules related to settlement and withdrawal are publicly available to ensure operational consistency.

    How to Use:

    1. Registration: Create an account through the CreditBlockchain website or app.

    2. Top-up: Add supported digital assets (BTC, XRP, ETH, or stablecoins) to the account.

    3. Plan Selection: Choose from available computing power plans, which include pricing and term information.

    4. Account Management: Settlements are applied to user balances daily and can be withdrawn to a linked on-chain wallet.

    Safety and Infrastructure:

    – Security: TLS 1.3 transport encryption, AES-256 data protection, login verification, and DDoS protection are implemented.

    – Operations: Data centers use N+1 power and cooling architecture with 24/7 monitoring and multi-regional disaster recovery to support continuous operation.

    – Transparency: Fees, parameters, and withdrawal records can be viewed and verified on-chain.

    A CreditBlockchain spokesperson stated:
    “Our goal is to provide a transparent and stable digital mining platform supported by verifiable on-chain data and standardized operational practices.”

    Company Vision
    CreditBlockchain aims to promote sustainable practices in digital computing and support technological advancement with operational transparency and environmental responsibility.

    Media Contact Information
    CreditBlockchain
    Official Website: creditblockchain.com
    Email: info@creditblockchain.com

    Contact Information:
    Credit Blockchain
    +447723578944
    Contact via Email
    creditblockchain.com

    Read the full story here: https://www.pr.com/press-release/953085

    Press Release Distributed by PR.com

  • Eminent Spine’s 3D Printed Titanium Posterior SI System Receives FDA 510(k) Clearance

    Plano, TX November 12, 2025 –(PR.com)– Eminent Spine, a leader in spinal implant innovation, proudly announces that its revolutionary 3D Printed Titanium Posterior SI System has received FDA 510(k) clearance as of October 7, 2025.

    Innovative Design & Superior Engineering
    The 3D Printed Titanium Posterior in-line transfixing implant was designed with both surgeon precision and patient outcomes in mind. Key features include:

    · SI Compression and Transfixation of SI joint
    · Aggressive Lordotic teeth to resist migration
    · Large central opening for maximum bone graft material
    · Tapered nose and rounded edges allows for ease of insertion

    Implant profiles are 25mm x 14mm x 8mm Lordotic implant.
    Screw options are offered in 3.5 or 3.75mm + lengths from 10-18mm.
    Implants have built-in locking tabs.

    Eminent Spine’s commitment to benchmark biomechanical testing and extensive cadaver biomechanical testing resulting in an anatomic 3D posterior transfixing implant. With the approval of the posterior approach and lateral, superior lateral and S2-AI approaches, Eminent Spine can now offer the patient and the surgeon a comprehensive system for SI joint fusion procedures. The multiple FDA approved approaches ensures safety, reliability and superior clinical outcomes.

    “With the 3D posterior titanium inline transfixing FDA 510(k) Eminent Spine is now able to offer a comprehensive system treating SI joint dysfunction,” says Dr. Stephen Courtney, Founder and CEO of Eminent Spine.

    This is Eminent Spine’s 9th FDA 510(k) clearance letter since 2020.

    About Eminent Spine
    Founded with a vision to redefine spinal solutions, Eminent Spine specializes in developing high-performance, surgeon-driven spinal implants. With a focus on biomechanics, surgical efficiency, and patient recovery, Eminent Spine remains at the forefront of orthopedic and spinal innovation.

    For more information about the 3D Printed Titanium Posterior SI System or to schedule a demonstration, please visit www.eminentspine.com.

    Contact Information:
    Eminent Spine
    Eminent Spine
    972-499-3593
    Contact via Email
    www.eminentspine.com

    Read the full story here: https://www.pr.com/press-release/953606

    Press Release Distributed by PR.com

  • Amana Care Clinic – Muscatine Expands Urgent Care Access with Enhanced Telehealth Platform

    Amana Care Clinic – Muscatine Expands Urgent Care Access with Enhanced Telehealth Platform

    MUSCATINE, IA – November 12, 2025 – PRESSADVANTAGE –

    Amana Care Clinic – Muscatine has expanded its telehealth platform to provide remote medical consultations for patients throughout Muscatine and surrounding Iowa communities, addressing the growing demand for accessible healthcare alternatives to traditional emergency room visits.

    The enhanced telehealth service enables patients to receive medical consultations from certified healthcare professionals without leaving their homes, complementing the clinic’s established walk in clinic services. The platform operates independently from the facility’s online reservation system and integrates seamlessly with existing medical records to ensure comprehensive care delivery.

    Amana Care Clinic - Muscatine

    “The expansion of our telehealth capabilities reflects our commitment to providing accessible healthcare options for the Muscatine community,” said Moutaz Kotob, PhD, Medical Director at Amana Care Clinic – Muscatine. “Patients experiencing non-emergency symptoms can now receive professional medical guidance remotely, helping them determine whether an in-person visit is necessary while avoiding unnecessary emergency room expenses and wait times.”

    The telehealth platform serves patients with various non-emergency conditions including cold symptoms, sinus infections, urinary tract infections, rashes, and minor injuries. Virtual consultations are conducted by the same certified healthcare professionals who staff the physical clinic locations, maintaining consistent care standards across all service channels.

    As an urgent care clinic, Amana Care Clinic – Muscatine continues to provide comprehensive in-person services for conditions requiring physical examinations or diagnostic testing. The facility maintains full laboratory services, X-ray capabilities, and treatment options for injuries, infections, childhood illnesses, and sports physicals. The telehealth option enhances these existing services by offering an initial assessment avenue for patients uncertain about the severity of their symptoms.

    The platform’s implementation follows industry-wide adoption of remote healthcare delivery methods, particularly for non-emergency medical needs. Patients utilizing the service can receive professional medical assessments that help distinguish between conditions requiring immediate in-person treatment and those manageable through remote consultation.

    “Our telehealth platform provides a valuable first point of contact for patients experiencing minor health concerns,” added Dr. Kotob. “This service helps reduce unnecessary emergency room visits while ensuring patients receive timely medical attention for their conditions.”

    The clinic’s dual approach of offering both remote consultations and walk-in services addresses varying patient needs and preferences. While telehealth consultations serve patients with mobility challenges or those seeking initial assessments, the physical location remains available for immediate care without appointments.

    Amana Care Clinic – Muscatine specializes in non-emergency medical care, offering shorter wait times than hospital emergency departments for minor to moderate health concerns. The clinic treats conditions ranging from abrasions and burns to fractures and infections, providing an affordable alternative to emergency room visits. With locations in both Muscatine and Davenport, Iowa, the clinic employs certified healthcare professionals equipped with diagnostic equipment including X-ray and laboratory facilities. The facility’s mission centers on delivering efficient, compassionate care in a patient-friendly environment, serving as a healthcare resource for residents and businesses throughout the region.

    ###

    For more information about Amana Care Clinic – Muscatine, contact the company here:

    Amana Care Clinic – Muscatine
    Moutaz Kotob, PhD
    (563) 263-1903
    moutazk@amanacareclinic.com
    1903 Park Ave Ste 1500
    Muscatine, IA 52761

  • Press Advantage Reveals How Local Businesses Win Online Visibility Through PR SEO Stack Strategy

    Press Advantage Reveals How Local Businesses Win Online Visibility Through PR SEO Stack Strategy

    Las Vegas, NV – November 12, 2025 – PRESSADVANTAGE –

    Press Advantage, a leading press release distribution platform, today revealed compelling data demonstrating how local businesses are achieving significant online visibility improvements through strategic press release distribution combined with search engine optimization techniques. The company’s analysis shows that businesses generating over 500 media citations alongside Google My Business map embeds are experiencing measurably higher local pack visibility in search results.

    The findings come as local businesses increasingly compete for limited spots in Google’s local search results, where appearing in the top three positions can determine whether potential customers discover a business. Press Advantage has documented numerous cases where consistent press release distribution creates a network of authoritative citations that search engines recognize as trust signals.

    “Local businesses often struggle to compete with larger competitors who have established domain authority and extensive backlink profiles,” said Jeremy Noetzelman, CEO of Press Advantage. “What we’re seeing is that strategic press release distribution creates a multiplier effect – each release generates dozens of media placements, and when combined with proper local SEO elements like map embeds and consistent NAP citations, businesses can dramatically improve their local search visibility within 90 to 120 days.”

    The approach, which Press Advantage calls the PR SEO Stack, involves distributing professionally written press releases to major news outlets, including ABC, NBC, CBS, and FOX affiliates, along with digital platforms like Yahoo Finance and Digital Journal. Each distribution creates multiple indexed pages containing the business name, location information, and relevant keywords, building what search engines interpret as increased relevance and authority.

    Press Advantage: Press Release Distribution Platform has served over 16,672 businesses since its founding in 2013, providing both writing and distribution services. The platform’s integration of SEO best practices into press release creation has evolved as search algorithms have become more sophisticated in evaluating content quality and relevance.

    The data reveals that businesses maintaining consistent monthly press release distribution see cumulative benefits, with each subsequent release building upon the authority established by previous distributions. This compound effect is particularly pronounced for local businesses targeting geographic-specific searches, where the combination of news citations and local signals creates a powerful ranking factor.

    “The key is consistency and strategic keyword placement,” added Noetzelman. “When a plumbing company in Dallas distributes monthly press releases about seasonal maintenance tips or community involvement, they’re not just getting temporary news coverage. They’re building a permanent digital footprint that search engines recognize as ongoing business activity and community relevance.”

    The Press Advantage Social Profile and distribution network includes placement on over 250 news outlets and their affiliates, creating a diverse citation profile that search engines value for local ranking determinations. The platform’s proprietary Reverse Research Keyword Spy Tool helps businesses identify the most effective keywords for their market, ensuring each release contributes to overall SEO objectives.

    Press Advantage operates as part of Velluto Tech Incubator, a cloud-hosted software company founded in Las Vegas, Nevada in 2011. The company specializes in helping businesses leverage news distribution for customer acquisition and search engine visibility, combining traditional public relations practices with modern digital marketing strategies.

    ###

    For more information about Press Advantage, contact the company here:

    Press Advantage
    Jeremy Noetzelman
    support@pressadvantage.com
    PO Box 29502 #84699
    Las Vegas, NV 89126

  • Adams Pool Solutions Expands Commercial Pool Construction Services for Hotels and Municipalities

    Adams Pool Solutions Expands Commercial Pool Construction Services for Hotels and Municipalities

    PLEASANTON, CA – November 12, 2025 – PRESSADVANTAGE –

    Adams Pool Solutions, a Northern California pool contractor operating since 1953, announced the expansion of its commercial pool construction division to address increasing demand from hotels, resorts, and municipal facilities throughout the region. The expansion includes additional project management teams and enhanced capabilities for large-scale aquatic installations requiring specialized engineering and regulatory compliance.

    The company has completed more than 29,000 projects over seven decades, with commercial pool construction representing a growing segment of its operations. The expanded division focuses on new construction and renovation projects for properties that serve high volumes of daily users, including luxury hotels, municipal aquatic centers, homeowners associations, and educational institutions.

    “Commercial pool projects require specialized knowledge of health department regulations, ADA compliance standards, and the operational demands of high-traffic facilities,” said Ray Langford, Marketing Director at Adams Pool Solutions. “Our expanded team brings together project managers, engineers, and construction specialists who understand the technical requirements of large-scale aquatic installations.”

    The expansion comes as Northern California experiences increased development of hospitality properties and public aquatic facilities. Hotels and resorts require pool installations that meet both aesthetic and operational standards, while municipal facilities must balance public access requirements with budget constraints and safety regulations.

    Adams Pool Solutions has integrated new technologies into its commercial projects, including energy-efficient circulation systems, automated chemical management equipment, and advanced surface materials designed for high-traffic environments. These systems reduce operational costs and maintenance requirements for commercial properties while extending facility lifespans.

    The company’s commercial division works with general contractors, architects, and engineering firms on projects ranging from boutique hotel pools to Olympic-sized municipal facilities. Recent projects have included complete mechanical system replacements, deck resurfacing, accessibility upgrades, and the installation of contemporary features that meet current safety standards.

    Municipal clients benefit from the company’s experience with public sector requirements, including competitive bidding processes, prevailing wage compliance, and coordination with multiple stakeholders. Educational institutions have utilized the company’s services for both new construction and renovation of aging facilities that require modernization to meet current standards.

    The timing of commercial pool projects presents particular challenges, as hotels must minimize disruptions during peak seasons and municipal facilities must maintain community access to aquatic programs. Adams Pool Solutions has developed project management protocols that address these scheduling constraints through detailed planning and dedicated commercial project teams.

    Renovation projects have become a significant component of the commercial division’s work, as facilities built decades ago require updates to meet contemporary safety standards and user expectations. These projects often involve complete mechanical system replacements, structural modifications, and the installation of modern equipment that improves both functionality and energy efficiency.

    Adams Pool Solutions maintains memberships with the California Pool and Spa Association, the National Plasterers Council, and the Pool and Hot Tub Alliance. The company operates from its Northern California base, serving commercial clients throughout the region with resources developed over seven decades of operation. The expanded commercial division represents the company’s response to market demand for specialized contractors capable of managing complex aquatic installations that serve thousands of users annually.

    ###

    For more information about Adams Pool Solutions, contact the company here:

    Adams Pool Solutions
    Ray Langford
    (925) 828-3100
    info@adamspools.com
    3675 Old Santa Rita Rd, Pleasanton, CA 94588